← Browse by Condition
Medical Condition

myelo dysplastic syndrome

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07098936 Phase 2
Recruiting

Momelotinib in VEXAS Syndrome

Enrollment
57 pts
Location
France
Sponsor
Groupe Francophone des Myelody...
View Trial →